Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA105667
Max Phase: Preclinical
Molecular Formula: C18H36N2
Molecular Weight: 280.50
Molecule Type: Small molecule
Associated Items:
ID: ALA105667
Max Phase: Preclinical
Molecular Formula: C18H36N2
Molecular Weight: 280.50
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCN1CCCC(C2CCCN2C)C1
Standard InChI: InChI=1S/C18H36N2/c1-3-4-5-6-7-8-14-20-15-9-11-17(16-20)18-12-10-13-19(18)2/h17-18H,3-16H2,1-2H3
Standard InChI Key: PNOYADQUASQUET-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 280.50 | Molecular Weight (Monoisotopic): 280.2878 | AlogP: 4.15 | #Rotatable Bonds: 8 |
Polar Surface Area: 6.48 | Molecular Species: BASE | HBA: 2 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 10.43 | CX LogP: 4.29 | CX LogD: 0.54 |
Aromatic Rings: 0 | Heavy Atoms: 20 | QED Weighted: 0.62 | Np Likeness Score: -0.18 |
1. Geldenhuys WJ, Lockman PR, McAfee JH, Fitzpatrick KT, Van der Schyf CJ, Allen DD.. (2004) Molecular modeling studies on the active binding site of the blood-brain barrier choline transporter., 14 (12): [PMID:15149650] [10.1016/j.bmcl.2004.04.020] |
Source(1):